Effect of IBMX and alkaline phosphatase inhibitors on Cl- secretion in G551D cystic fibrosis mutant mice

American Journal of Physiology - Cell Physiology

Volumn 274, Issue 2 43-2, 1998, Pages

  Smith, Stephen N ^a   Delaney, Stephen J ^b   Dorin, Julia R ^c   Farley, Raymond ^a   Geddes, Duncan M ^a   Porteous, David J ^c   Wainwright, Brandon J ^b   Alton, Eric W F W ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

3 isobutyl 1 methylxanthine; Cystic fibrosis transmembrane conductance regulator; Mouse model

Indexed keywords

ALKALINE PHOSPHATASE; CHLORIDE CHANNEL; CHLORIDE ION; ISOBUTYLMETHYLXANTHINE; LEVAMISOLE; MUTANT PROTEIN; TETRAMISOLE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APICAL MEMBRANE; ARTICLE; CHLORIDE CONDUCTANCE; CONTROLLED STUDY; CYSTIC FIBROSIS; GENE MUTATION; INTESTINE; MOUSE; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RESPIRATORY SYSTEM;

ANIMALIA;

EID: 0031888308     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1998.274.2.c492     Document Type: Article

References (31)

1. Abdel-Meguid, M. S., K. Badr, and M. Saif. The polyanthelmintic efficacy of levamisole. J. Egyptian Med. Assoc. 58: 334-336, 1975.
2. Abrahamsen, N., K. Lundgren, and E. Nishimura. Regulation of glucagon receptor mRNA in cultured primary rat hepatocytes by glucose and cAMP. J. Biol. Chem. 270: 15853-15857, 1995.
3. Beavo, J. A. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev. 75: 725-748, 1995.
4. Becq, F., T. J. Jensen, X.-B. Chang, A. Savoia, J. M. Rommens, L.-C. Tsui, M. Buchwald, J. Riordan, and J. W. Hanrahan. Phosphatase inhibitors activate normal and defective cftr chloride channels. Proc. Natl. Acad. Sci. USA 91: 9160-9164, 1994.
5. - channel by specific protein kinases and protein phosphatases. J. Biol. Chem. 268: 2037-2047, 1993.
6. Colledge, W. H., B. S. Abella, K. W. Southern, R. Ratcliff, C. Jiang, S. H. Cheng, L. J. MacVinish, J. R. Anderson, A. W. Cuthbert, and M. J. Evans. Generation and characterisation of a ΔF508 cystic fibrosis mouse model. Nat. Genet. 10: 445-452, 1995.
7. Delaney, S. J., E. W. F. W. Alton, S. N. Smith, D. P. Lunn, R. Farley, P. K. Lovelock, S. A. Thomson, D. A. Hume, D. Lamb, D. J. Porteous, J. R. Dorin, and B. J. Wainwright. Cystic fibrosis mice carrying the missense mutation G551D replicate human genotype/phenotype correlations. EMBO J. 15: 955-963, 1996.
8. Denning, G. M., M. P. Anderson, J. F. Amara, J. Marshall, A. E. Smith, and M. J. Welsh. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358: 761-764, 1992.
9. Dorin, J. R., R. Farley, S. Webb, S. N. Smith, E. Farini, S. J. Delaney, B. J. Wainwright, E. W. F. W. Alton, and D. J. Porteous. A demonstration using mouse models that successful gene therapy for cystic fibrosis requires only partial gene correction. Gene Ther. 3: 797-801, 1996.
10. Drumm, M. L., D. J. Wilkinson, L. S. Smit, R. T. Worrell, T. V. Strong, R. A. Frizzell, D. C. Dawson, and F. S. Collins. Chloride conductance expressed by ΔF508 and other mutant CFTRs in Xenopus oocytes. Science 254: 1797-1799, 1991.
11. Fuller, C. M., and D. J. Benos. CFTR! Am. J. Physiol. 263 (Cell Physiol. 32): C267-C286, 1992.
12. Gadsby, D. C., and A. G. Nairn. Regulation of CFTR channel gating. Trends Biochem. Sci. 19: 513-518, 1994.
13. Grubb, B. R., E. Lazarowski, M. Knowles, and R. C. Boucher. Isobutylmethylxanthine fails to stimulate chloride secretion in cystic fibrosis airway epithelia. Am. J. Respir. Cell Mol. Biol. 8: 454-460, 1993.
14. Hamosh, A., T. M. King, B. J. Rosenstein, M. Corey, H. Levison, P. Durie, L.-C. Tsui, I. McIntosh, M. Keston, D. J. H. Brock, M. Macek, D. Zemkova, H. Krasnicanova, V. Vavrova, N. Golder, M. J. Schwarz, M. Super, E. K. Watson, C. Williams, A. Bush, S. M. O'Mahoney, P. Humphries, M. A. DeArce, A. Reis, J. Burger, M. Stuhrmann, J. Schmidtke, U. Wulbrand, T. Dork, B. Tummler, and G. R. Cutting. Cystic fibrosis patients bearing both the common missense mutation Gly - Asp at codon 551 and the deltaF508 mutation are clinically indistinguishable from delta F508 homozygotes, except for decreased risk of meconium ileus. Am. J. Hum. Genet. 51: 245-250, 1992.
15. Hanrahan, J. W., F. Becq, J. A. Tabcharani, T. J. Jensen, X.-B. Chang, and J. R. Riordan. Use of phosphatase inhibitors as therapeutic agents to activate mutant CFTR. Pediatr. Pulmonol. Suppl. 12: 152-153, 1995.
16. - conductance in mammalian heart. J. Gen. Physiol. 101: 629-650, 1993.
17. Hwang, T.-C., G. Nagel, A. C. Nairn, and D. C. Gadsby. Regulation of the gating of cystic fibrosis transmembrane conductance regulator Cl channels by phosphorylation and ATP hydrolysis. Proc. Natl. Acad. Sci. USA 91: 4698-4702, 1994.
18. Letellier, M., N. Briere, G. E. Plante, and C. Petitclerc. Phosphate transport and alkaline phosphatase in confluent MDCK cell monolayers. Can. J. Physiol. Pharmacol. 65: 1151-1156, 1987.
19. Mackintosh, C., and R. W. Mackintosh. Inhibitors of protein kinases and phosphatases. Trends Biochem. Sci. 19: 444-448, 1994.
20. Manolopoulos, V. G., M. M. Samet, and P. I. Lelkes. Regulation of the adenylyl cyclase signaling system in various types of cultured endothelial cells. J. Cell. Chem. 57: 590-598, 1995.
21. O'Loughlin, E. V., D. M. Hunt, K. J. Gaskin, D. Stiel, I. M. Bruzuszcak, C. O. Martin, C. Bambach, and R. Smith. Abnormal epithelial transport in cystic fibrosis jejunum. Am. J. Physiol. 260 (Gastrointest. Liver Physiol. 23): G758-G763, 1991.
22. Snouwaert, J. N., K. K. Brigman, A. M. Latour, N. N. Malouf, R. C. Boucher, O. Smithies, and B. Koller. An animal model for cystic fibrosis made by gene targeting. Science 257: 1083-1088, 1992.
23. Smith, S. N., J. R. Dorin, S. J. Delaney, D. M. Geddes, B. Wainwright, D. J. Porteous, and E. W. F. W. Alton. Tracheal bioelectric characteristics of CF mouse models (Abstract). Pediatr. Pulmonol. Suppl. 12: 214, 1995.
24. Smith, S. N., D. M. Steel, P. G. Middleton, F. M. Munkonge, D. M. Geddes, N. J. Caplen, D. J. Porteous, J. R. Dorin, and E. W. F. W. Alton. Bioelectric properties of exon 10 insertional cystic fibrosis mouse: comparison with humans. Am. J. Physiol. 268 (Cell Physiol. 37): C297-C307, 1995.
25. - channel in CHO cells stably expressing the cystic fibrosis gene. Nature 352: 628-631, 1991.
26. Takahara, N., F. Herz, R. M. Singer, A. Hirano, and L. G. Koss. Induction of alkaline phosphatase activity in cultured human intracranial tumor cells. Cancer Res. 42: 563-568, 1982.
27. Tomashefski, J. F., Jr., C. R. Abramowsky, and B. B. Dahms. The pathology of cystic fibrosis. In: Cystic Fibrosis, edited by P. B. Davis. New York: Dekker, 1993, p. 435-489. (Lung Biol. Health Dis. Ser., vol. 64)
28. Tomashefski, J. F., Jr., C. R. Abramowsky, and B. B. Dahms. The pathology of cystic fibrosis. In: Cystic Fibrosis, edited by P. B. Davis. New York: Dekker, 1993, p. 435-489. (Lung Biol. Health Dis. Ser., vol. 64)
29. Van Doorninck, J. H., P. J. French, E. Verbeek, R. H. P. C. Peters, H. Morreau, J. Bijman, and B. J. Scholte. A mouse model for the cystic fibrosis ΔF508 mutation. EMBO J. 14: 4403-4411, 1995.
30. Welsh, M. J., and A. E. Smith. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73: 1251-1254, 1993.
31. Zeiher, B. G., E. E. Zabner, J. J. Smith, A. P. Puga, P. B. McCray, M. R. Capecchi, M. J. Welsh, and K. R. Thomas. A mouse model for the delta-F508 allele of cystic fibrosis. J. Clin. Invest. 96: 2051-2064, 1995.